HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Uwe Haberkorn Selected Research

Adenocarcinoma

1/2024Immunohistochemical FAP Expression Reflects 68Ga-FAPI PET Imaging Properties of Low- and High-Grade Intraductal Papillary Mucinous Neoplasms and Pancreatic Ductal Adenocarcinoma.
10/2023Comparison of early and late 68Ga-FAPI-46-PET in 33 patients with possible recurrence of pancreatic ductal adenocarcinomas.
1/2023Joint EANM/SNMMI procedure guideline for the use of 177Lu-labeled PSMA-targeted radioligand-therapy (177Lu-PSMA-RLT).
1/2021Impact of 68Ga-FAPI PET/CT Imaging on the Therapeutic Management of Primary and Recurrent Pancreatic Ductal Adenocarcinomas.
1/2020Response Prediction of 177Lu-PSMA-617 Radioligand Therapy Using Prostate-Specific Antigen, Chromogranin A, and Lactate Dehydrogenase.
3/2015Antibody therapy to human L1CAM in a transgenic mouse model blocks local tumor growth but induces EMT.
7/2014Inhibition of glucose turnover by 3-bromopyruvate counteracts pancreatic cancer stem cell features and sensitizes cells to gemcitabine.
3/2013Assessment of diffusion-weighted MRI and 18F-fluoro-deoxyglucose PET/CT in monitoring early response to neoadjuvant chemotherapy in adenocarcinoma of the esophagogastric junction.
6/2011Sequential FDG-PET and induction chemotherapy in locally advanced adenocarcinoma of the Oesophago-gastric junction (AEG): the Heidelberg Imaging program in Cancer of the oesophago-gastric junction during Neoadjuvant treatment: HICON trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Uwe Haberkorn Research Topics

Disease

171Neoplasms (Cancer)
04/2024 - 01/2003
101Prostatic Neoplasms (Prostate Cancer)
12/2023 - 01/2005
29Neoplasm Metastasis (Metastasis)
10/2023 - 01/2003
16Melanoma (Melanoma, Malignant)
03/2021 - 12/2002
13Carcinoma (Carcinomatosis)
01/2019 - 03/2002
11Lung Neoplasms (Lung Cancer)
04/2024 - 04/2014
11Glioma (Gliomas)
01/2022 - 12/2010
11Hepatocellular Carcinoma (Hepatoma)
08/2010 - 05/2003
10Neuroendocrine Tumors (Neuroendocrine Tumor)
05/2023 - 01/2003
9Adenocarcinoma
01/2024 - 06/2011
8Pancreatic Neoplasms (Pancreatic Cancer)
11/2023 - 07/2014
8Colorectal Neoplasms (Colorectal Cancer)
10/2021 - 08/2008
8Experimental Liver Neoplasms
01/2007 - 05/2003
7Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 07/2006
7Meningioma (Meningiomas)
04/2018 - 05/2005
6Infections
02/2024 - 03/2008
6Hypoxia (Hypoxemia)
11/2022 - 04/2011
6Lymphatic Metastasis
03/2022 - 07/2013
6Lymphoma (Lymphomas)
01/2022 - 04/2007
6Xerostomia
10/2021 - 06/2017
6Glioblastoma (Glioblastoma Multiforme)
09/2020 - 03/2014
5Breast Neoplasms (Breast Cancer)
07/2023 - 09/2005
5Pain (Aches)
04/2021 - 06/2012
5Sarcoma (Soft Tissue Sarcoma)
01/2021 - 03/2008
5Thyroid Neoplasms (Thyroid Cancer)
08/2018 - 05/2004
5Alzheimer Disease (Alzheimer's Disease)
01/2016 - 10/2003
5Cognitive Dysfunction
01/2016 - 06/2006
4Squamous Cell Carcinoma of Head and Neck
11/2018 - 03/2009
3Head and Neck Neoplasms (Head and Neck Cancer)
09/2020 - 03/2002
3Myocardial Infarction
01/2020 - 06/2005
3Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2018 - 03/2016
3Transthyretin-Related Hereditary Amyloidosis
05/2014 - 12/2007
3Astrocytoma (Pilocytic Astrocytoma)
03/2014 - 11/2002
3Experimental Melanoma
12/2006 - 10/2004

Drug/Important Bio-Agent (IBA)

54AntigensIBA
05/2023 - 02/2011
48LigandsIBA
12/2023 - 12/2002
41Proteins (Proteins, Gene)FDA Link
04/2024 - 01/2004
34Peptides (Polypeptides)IBA
01/2020 - 04/2003
29gallium 68 PSMA-11IBA
04/2020 - 10/2013
22Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
07/2023 - 03/2002
2168Ga-FAPIIBA
01/2024 - 01/2018
21Glucose (Dextrose)FDA LinkGeneric
01/2019 - 03/2002
15RadiopharmaceuticalsIBA
11/2023 - 09/2005
15Radioisotopes (Radionuclides)IBA
10/2021 - 04/2005
10N,N'- bis(2- hydroxy- 5- (ethylene- beta- carboxy)benzyl)ethylenediamine N,N'-diacetic acidIBA
01/2018 - 04/2012
9Prostate-Specific Antigen (Semenogelase)IBA
10/2021 - 01/2012
91,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2019 - 01/2003
9Edotreotide (SMT 487)IBA
11/2017 - 01/2003
8PSMA-617IBA
02/2022 - 06/2015
7AntibodiesIBA
01/2024 - 11/2011
7FAPI-46IBA
10/2023 - 01/2020
7Biomarkers (Surrogate Marker)IBA
01/2022 - 05/2014
7Somatostatin Receptors (Somatostatin Receptor)IBA
12/2021 - 01/2003
6CarbonIBA
01/2021 - 04/2013
6AcidsIBA
01/2018 - 01/2005
6IodidesIBA
12/2010 - 05/2003
5Dihydrotachysterol (AT 10)IBA
12/2022 - 01/2007
5IntegrinsIBA
01/2021 - 12/2011
5IonsIBA
01/2021 - 01/2018
5IpilimumabIBA
01/2021 - 03/2015
5BombesinIBA
01/2018 - 01/2005
5Urea (Carbamide)FDA LinkGeneric
01/2016 - 04/2012
5BenzamidesIBA
01/2014 - 12/2002
5sodium-iodide symporter (sodium iodide symporter)IBA
12/2010 - 05/2003
4AndrogensIBA
01/2023 - 07/2017
4DNA (Deoxyribonucleic Acid)IBA
11/2022 - 03/2005
4Amino AcidsFDA Link
11/2022 - 04/2004
4Hormones (Hormone)IBA
11/2021 - 01/2016
4SFITGv6 peptideIBA
01/2021 - 08/2017
4Protons (Proton)IBA
01/2021 - 04/2004
4Fluorine-18IBA
12/2018 - 03/2002
4benzamideIBA
07/2018 - 12/2002
4Melanins (Melanin)IBA
07/2018 - 10/2005
4Cetuximab (Erbitux)FDA Link
07/2018 - 07/2011
4Bombesin Receptors (Bombesin Receptor)IBA
01/2018 - 04/2005
4AlbuminsIBA
01/2017 - 01/2005
4Carbonic Anhydrase IXIBA
10/2012 - 12/2010
4ElementsIBA
12/2006 - 12/2002
3Immunoconjugates (Immunoconjugate)IBA
10/2022 - 03/2016
3Therapeutic UsesIBA
01/2022 - 05/2006
3Chelating AgentsIBA
10/2021 - 01/2016
3EnzymesIBA
07/2019 - 12/2010
3Rituximab (Mabthera)FDA Link
10/2018 - 03/2016
3Ga(III)-DOTATOCIBA
04/2018 - 05/2010
3Antineoplastic Agents (Antineoplastics)IBA
01/2017 - 01/2005
3Peptide Receptors (Peptide Receptor)IBA
05/2016 - 06/2007
3Somatostatin (Somatotropin Release-Inhibiting Factor)IBA
05/2010 - 05/2005

Therapy/Procedure

102Therapeutics
12/2023 - 03/2002
36Radiotherapy
01/2022 - 11/2002
23Castration
12/2023 - 07/2014
17Drug Therapy (Chemotherapy)
01/2021 - 12/2006
13Precision Medicine
12/2023 - 06/2015
7Immunotherapy
03/2021 - 04/2014
7Prostatectomy (Retropubic Prostatectomy)
01/2021 - 03/2017
5Radioimmunotherapy
01/2019 - 07/2011
4Lymph Node Excision (Lymph Node Dissection)
01/2021 - 07/2013
3Gamma Cameras (Gamma Camera)
12/2023 - 05/2006
3Re-Irradiation
10/2018 - 04/2013
3Neoadjuvant Therapy
03/2013 - 04/2010
3Chemoradiotherapy
06/2011 - 04/2007